Aegis Therapeutics Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Aegis Therapeutics General Information
Description
Developer of drug delivery agents and formulations designed to support the non-invasive delivery of drugs into patients' systems. The company's products enable the systematic delivery of peptides protein, nucleotide-related, and other small and large molecule drugs without injections, allowing patients to eliminate the need for needles and disposal tissues.
Contact Information
Website
www.aegisthera.comCorporate Office
- 11770 Bernardo Plaza Court
- Suite 353
- San Diego, CA 92130
- United States
Corporate Office
- 11770 Bernardo Plaza Court
- Suite 353
- San Diego, CA 92130
- United States
Aegis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aegis Therapeutics Comparisons
Industry
Financing
Details
Aegis Therapeutics Competitors (15)
One of Aegis Therapeutics’s 15 competitors is Regenerative Medical Solutions, a Venture Capital-Backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regenerative Medical Solutions | Venture Capital-Backed | Madison, WI | ||||
| Acuitas Therapeutics | Corporation | Vancouver, Canada | ||||
| Acousia Therapeutics | Venture Capital-Backed | Tubingen, Germany | ||||
| Thabor Therapeutics | Venture Capital-Backed | Paris, France | ||||
| LEO Pharma | Private Equity-Backed | Ballerup, Denmark |
Aegis Therapeutics Patents
Aegis Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3969054-A1 | Oil-soluble drug containing compositions and methods of use thereof | Inactive | 16-May-2019 | ||
| EP-3969054-A4 | Oil-soluble drug containing compositions and methods of use thereof | Inactive | 16-May-2019 | ||
| US-20200360292-A1 | Oil-soluble drug containing compositions and methods of use thereof | Inactive | 16-May-2019 | ||
| WO-2020232379-A1 | Oil-soluble drug containing compositions and methods of use thereof | Inactive | 16-May-2019 | ||
| US-10682414-B2 | Intranasal epinephrine formulations and methods for the treatment of disease | Active | 21-Dec-2018 | A61K47/26 |
Aegis Therapeutics FAQs
-
When was Aegis Therapeutics founded?
Aegis Therapeutics was founded in 2003.
-
Where is Aegis Therapeutics headquartered?
Aegis Therapeutics is headquartered in San Diego, CA.
-
What industry is Aegis Therapeutics in?
Aegis Therapeutics’s primary industry is Drug Delivery.
-
Is Aegis Therapeutics a private or public company?
Aegis Therapeutics is a Private company.
-
What is Aegis Therapeutics’s current revenue?
The current revenue for Aegis Therapeutics is .
-
Who are Aegis Therapeutics’s competitors?
Regenerative Medical Solutions, Acuitas Therapeutics, Acousia Therapeutics, Thabor Therapeutics, and LEO Pharma are some of the 15 competitors of Aegis Therapeutics.
-
When was Aegis Therapeutics acquired?
Aegis Therapeutics was acquired on 03-Dec-2018.
-
Who acquired Aegis Therapeutics?
Aegis Therapeutics was acquired by Neurelis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process